Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 301
Ph III recruiting: 41
Growth YoY: +4.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 1–50 of 112 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04359732	Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI(Escape)	completed	N/A	121	IRCCS San RaffaeleOTHER	1	Sep 21, 2026	clinicaltrials
NCT05281380	VITAMin Insufficiency in Esophagogastric Neoplasms(VITAMIN)	completed	N/A	107	Zuyderland Medisch CentrumOTHER	1	Sep 4, 2026	clinicaltrials